Cytosorbents (CTSO) Change in Cash (2010 - 2026)
Cytosorbents' (CTSO) quarterly Change in Cash came in at -$1.4 million in Q1 2026, down 142.92% YoY from $3.3 million in Q1 2025, and down 11.58% on a QoQ basis from -$1.3 million in Q4 2025.
Cytosorbents (CTSO) Change in Cash (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Change in Cash data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Change in Cash fell 142.92% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 324.5% YoY) and the FY2025 annual result came in at -$2.0 million, up 65.94% from the prior year.
- Change in Cash eased to -$1.4 million in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $5.6 million in Q4 2023 to a low of -$12.9 million in Q2 2022.
- A 5-year average of -$2.8 million and a median of -$2.7 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash sank 349.73% — and 2023, when it surged 1465.95%.
- Tracing CTSO's Change in Cash over 5 years: stood at -$407672.0 in 2022, then surged by 1465.95% to $5.6 million in 2023, then slumped by 143.17% to -$2.4 million in 2024, then soared by 46.46% to -$1.3 million in 2025, then decreased by 11.58% to -$1.4 million in 2026.
- The last three Change in Cash figures came in at -$1.4 million (Q1 2026), -$1.3 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -400,000.00 |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | -1.29 Mn |
| Sep 30, 2025 | -2.67 Mn |
| Jun 30, 2025 | -1.38 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | -5.52 Mn |
| Dec 31, 2023 | 5.57 Mn |
| Sep 30, 2023 | -4.79 Mn |
| Jun 30, 2023 | -5.90 Mn |
| Mar 31, 2023 | -3.10 Mn |
| Dec 31, 2022 | -407,672.00 |
| Sep 30, 2022 | -7.61 Mn |
| Jun 30, 2022 | -12.86 Mn |
| Mar 31, 2022 | -9.11 Mn |
| Dec 31, 2021 | -7.22 Mn |
| Sep 30, 2021 | -4.57 Mn |